Evidence for pre-hepatic metabolism of oral cyclosporine in children

scientific article

Evidence for pre-hepatic metabolism of oral cyclosporine in children is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2125.1991.TB03934.X
P932PMC publication ID1368609
P698PubMed publication ID1958443
P5875ResearchGate publication ID21198449

P2093author name stringHolmberg C
Hoppu K
Koskimies O
Hirvisalo EL
P2860cites workIdentification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and manQ35580014
Clinical pharmacokinetics of cyclosporinQ39729593
Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjectsQ43777952
Small-bowel length and the dose of cyclosporine in children after liver transplantationQ68718874
Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporineQ68920584
Absorption of cyclosporine A after oral dosingQ68920610
New automated high-performance liquid chromatographic analysis of cyclosporin A and G in human serumQ68963443
Biotransformation and distribution in blood of cyclosporine and its metabolitesQ69677371
Small-intestine length in infants and childrenQ71229411
Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dogQ34396798
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcyclosporineQ367700
P304page(s)477-481
P577publication date1991-10-01
P1433published inBritish Journal of Clinical PharmacologyQ176044
P1476titleEvidence for pre-hepatic metabolism of oral cyclosporine in children
P478volume32

Reverse relations

cites work (P2860)
Q51955888A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
Q80223463A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients
Q46790074Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children
Q41508751Cyclosporin pharmacokinetics in paediatric transplant recipients
Q40490594Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders
Q61591067Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children
Q33813327Cytochrome P450 3A: ontogeny and drug disposition
Q42283823Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
Q53901793Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients.
Q39108777Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study
Q35831389Long-term follow-up after staged reconstruction or transplantation for patients with functionally univentricular heart
Q40862165Paediatric kidney transplantation
Q54229714Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type.
Q44373816Predictive value of pretransplantation cyclosporine pharmacokinetic studies on initial post-transplantation dosing in pediatric kidney allograft recipients
Q72896888Renal function and histopathologic changes in children after liver transplantation
Q72695226Renal transplantation in children with emphasis on young patients
Q41623144The use of lidocaine as a test of liver function in liver transplantation
Q34345648Trough concentrations of cyclosporine in blood following administration with grapefruit juice

Search more.